African Health Sciences

Papers
(The H4-Index of African Health Sciences is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Effect of whole course seamless nursing mode on patients with chronic infectious wounds56
The association between headache presentation, normal examination and neuroimaging findings: a retrospective analysis of patients presenting to a tertiary referral centre30
A 10-year clinicopathological analysis of ovarian lesions in a tertiary hospital in Southern Nigeria25
The burden of schistosomiasis among school-aged children in Ogoja, Nigeria: current level of infection years after mass drug administration with Praziquantel25
The integrity of psychophysical visual function in non-immunocompromised PLHIV (NIPLHIV) without retinitis on antiretroviral therapy (ART)19
Takayasu arteritis, an atypical presentation as chronic kidney disease16
Covid-19 and non-communicable diseases (NCDs) in Africa: a narrative review14
Multiple anti-seizure medications use and pattern of seizure control in children with epilepsy at neurology follow up clinic, Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia14
Total intravenous anaesthesia in rural sub-Saharan Africa: report of 25 cases14
Lesch-Nyhan syndrome a dental approach: case report13
Burden of virologic failure, and its determinants among HIV positive children in East Africa: a systematic review and meta-analysis13
Prevalence of gastrointestinal bleeding and frequency of selected predictors of mortality on the medical emergency ward at Mulago hospital13
Assessment of knowledge and socioeconomic status of caregivers of children with malnutrition at a district hospital in Ghana13
Prevalence of venous thromboembolism risk factors in hospitalized patients at the University of Nigeria Teaching Hospital, Enugu Nigeria13
Evaluation of treatment efficacy after switching to dolutegravir-lamivudine dual therapy in people living with HIV13
0.11387395858765